These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6187640)

  • 21. Virus safety of pasteurized antithrombin III concentrate.
    Roggendorf M; Delvos U; Nováková-Banet A
    Thromb Haemost; 1991 Feb; 65(2):212. PubMed ID: 1647061
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment with AT III concentrates in hereditary and acquired AT III deficiency.
    Gromnica-Ihle E; Ziemer S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):307-13. PubMed ID: 2465221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heterogeneity of mammalian antithrombin III].
    Bashkov GV; Kalishevskaia TM; Strukova SM
    Biokhimiia; 1989 Nov; 54(11):1797-803. PubMed ID: 2627551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic behaviour of antithrombin III following intravenous infusion in healthy volunteers.
    Marzo A; Ceppi-Monti N; Giusti A; Abbiati G; Parenti M
    Arzneimittelforschung; 2002; 52(3):187-93. PubMed ID: 11963646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antithrombin III inhibition of the reaction to thrombin excitation of the anticoagulation system].
    Strukova SM; Umarova BA; Golubeva MG; Dugina TN; Bashkov GV
    Biull Eksp Biol Med; 1987 Mar; 103(3):268-70. PubMed ID: 3828498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic changes produced by complex formation between thrombin and antithrombin-III.
    McDuffie FC; Peterson JM; Clark G; Mann KG
    J Immunol; 1981 Jul; 127(1):239-44. PubMed ID: 6787123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombin III concentrates.
    Menache D
    Hematol Oncol Clin North Am; 1992 Oct; 6(5):1115-20. PubMed ID: 1400075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification and further characterization of antithrombin III Milano: lack of reactivity with thrombin.
    Wolf M; Boyer-Neumann C; Meyer D; Tripodi A; Mannucci PM; Larrieu MJ
    Thromb Haemost; 1987 Oct; 58(3):888-92. PubMed ID: 3433251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia.
    Sas G; Blaskó G; Bánhegyi D; Jákó J; Pálos LA
    Thromb Diath Haemorrh; 1974 Sep; 32(1):105-15. PubMed ID: 4454033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Abnormal antithrombin III].
    Sakuragawa N
    Rinsho Byori; 1987 Apr; Spec No 70():187-201. PubMed ID: 3302389
    [No Abstract]   [Full Text] [Related]  

  • 35. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 36. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].
    Priĭmak AA; Makinskiĭ AI; Ivan'ko TP; Makarova VV
    Vrach Delo; 1990 May; (5):73-4. PubMed ID: 2396401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombin III does not have bound glucocerebroside.
    Dale GL; Westwood B
    Biochim Biophys Acta; 1981 Jul; 669(2):260-2. PubMed ID: 7284440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adsorption of 99mTc(Sn)-diphosphonate complexes on tri-calciumphosphate: the influence of preparation conditions, ligand-type, incubation media and adsorption conditions. The reversibility of the adsorption.
    Huigen YM; Krips HJ; Hulleman S; Gelsema WJ; De Ligny CL
    Int J Rad Appl Instrum A; 1990; 41(2):189-94. PubMed ID: 2158946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of antithrombin III (human).
    Nunez H; Drohan WN
    Semin Hematol; 1991 Jan; 28(1):24-30. PubMed ID: 2017688
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.